Company overview
Primerdesign is a leader in real-time qPCR solutions, offering precision-designed primers, probes, and assays for life sciences and pharmaceutical applications. Their products support gene expression analysis, pathogen detection, and diagnostics, ensuring high specificity and reliability in R&D workflows. They provide ready-to-use kits and custom solutions optimized for quantitative PCR.
Primer Design is listed in the NovaPharmaNews Supplier Hub as a Diagnostics & Testing partner serving United States & Americas. Core focus areas include qpcr primers, real-time pcr assays, primerdesign, pharma suppliers, gene expression kits.
Industry categories: Diagnostics & Testing. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Structured facts
- Website
- https://www.primerdesign.co.uk/
- Categories
- Diagnostics & Testing
- Markets served
- United States & Americas
- Keywords
- qpcr primers, real-time pcr assays, primerdesign, pharma suppliers, gene expression kits
Products & technologies
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What qPCR products and capabilities does Primerdesign offer?
- Primerdesign offers real-time qPCR primers, probes, assays, and kits for gene expression, pathogen detection, and diagnostics, with precision design for high specificity and sensitivity.
- What regulatory standards does Primerdesign comply with?
- Primerdesign products meet ISO standards and are designed for regulated environments like clinical diagnostics and pharmaceutical R&D, ensuring compliance for sensitive applications.
- What geographies does Primerdesign serve?
- Primerdesign, based in the UK, supplies globally to pharmaceutical and life sciences customers in Europe, North America, Asia, and other regions.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
